Hubei Goto Biopharm Co.,Ltd. (300966.SZ)
CNY 17.5
(-0.91%)
CNY 17.5
(-0.91%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 68.13 Million | -24.03 Million | 58 Million | 13.47 Million | 8.5 Million | -47.89 Million |
| Net Income | 21.28 Million | 39.49 Million | 78.06 Million | 53.19 Million | 72.99 Million | 70.67 Million |
| Depreciation & Amortization | 28.2 Million | 27.23 Million | 23.35 Million | 21.18 Million | 17.03 Million | 15.14 Million |
| Deferred income taxes | -5.4 Million | -8.08 Million | -5.38 Million | 370.25 Thousand | -1 Million | -661.6 Thousand |
| Stock-based compensation | 1.68 Million | - | - | - | - | - |
| Change in working capital | -13.72 Million | -109.66 Million | -54.91 Million | -71.77 Million | -98.97 Million | -140.77 Million |
| Other non-cash items | 16.49 Million | 18.9 Million | 11.49 Million | 10.86 Million | 17.44 Million | 7.05 Million |
| Investing Cash Flow | -402.34 Million | -456.3 Million | -105.41 Million | -18.51 Million | -33.07 Million | 1.63 Million |
| Investments in PPE | -409.25 Million | -407.93 Million | -90.87 Million | -18.56 Million | -33.27 Million | -13.9 Million |
| Acquisitions | 19.6 Million | 133.49 Thousand | 16.32 Million | 5.44 Million | 10 Thousand | 4000.00 |
| Investment purchases | - | -33.6 Million | -14.4 Million | -5.44 Million | -10 Thousand | - |
| Sales/Maturities of investments | 8940.33 | 234.12 | -16.32 Million | 40.75 | 189.1 Thousand | 236.98 Thousand |
| Other Investing Activities | 6.89 Million | -14.89 Million | -136.91 Thousand | 48.16 Thousand | 10 Thousand | 15.3 Million |
| Financing Cash Flow | 15.59 Million | 713.29 Million | 207 Million | -30.44 Million | 71.72 Million | 50.72 Million |
| Debt repayment | -3.31 Million | -250.44 Million | -156.76 Million | -161.56 Million | -114.42 Million | -85.58 Million |
| Dividends payments | -6.09 Million | -15.67 Million | -7.57 Million | -9.16 Million | -9.26 Million | -4.62 Million |
| Common Stock Repurchased | - | - | 13.97 Million | - | - | - |
| Common Stock Issuance | - | - | -13.97 Million | - | - | - |
| Other Financing Activities | 18.37 Million | 990.64 Million | 371.34 Million | 140.29 Million | 195.42 Million | 140.93 Million |
| Accounts receivables | -60.59 Million | -34.65 Million | 20.23 Million | -66.29 Million | -79.66 Million | -66.79 Million |
| Accounts payables | 62.04 Million | -6.49 Million | 103.57 Million | -48.84 Million | 31.19 Million | 19.1 Million |
| Inventory | -9.76 Million | -60.42 Million | -173.33 Million | 43 Million | -49.49 Million | -92.42 Million |
| Other working capital | 1.68 Million | -8.08 Million | -5.38 Million | 370.25 Thousand | -1 Million | -48.35 Million |
| Cash at beginning of period | 415.14 Million | 181.91 Million | 22.76 Million | 58.18 Million | 11.73 Million | 7.43 Million |
| Cash at end of period | 96.2 Million | 415.14 Million | 181.91 Million | 22.76 Million | 58.18 Million | 11.73 Million |
| Capital Expenditure | -409.25 Million | -407.93 Million | -90.87 Million | -18.56 Million | -33.27 Million | -13.9 Million |
| Effect of forex changes on cash | -321.13 Thousand | 278.15 Thousand | -436.76 Thousand | 64.73 Thousand | -712.94 Thousand | -162.34 Thousand |
| Net cash flow / Change in cash | -318.94 Million | 233.23 Million | 159.15 Million | -35.42 Million | 46.44 Million | 4.29 Million |
| Free Cash Flow | -341.12 Million | -431.97 Million | -32.87 Million | -5.09 Million | -24.76 Million | -61.8 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -9.04 Million | -8.66 Million | 3.54 Million | 220.53 Thousand | 21.28 Million | 5.31 Million |
| Depreciation & Amortization | - | 7.82 Million | 7.82 Million | 28.2 Million | 28.2 Million | -14.52 Million |
| Deferred income taxes | - | - | - | - | -5.4 Million | -21.98 Million |
| Stock-based compensation | - | 1.4 Million | - | 1.68 Million | 1.68 Million | -1.37 Million |
| Change in working capital | - | 9.66 Million | - | -68.67 Million | -13.72 Million | 37.88 Million |
| Other non-cash items | 68.2 Million | 74.82 Million | -27.76 Million | 98.97 Million | 16.49 Million | 43.5 Million |
| Investing Cash Flow | -151.6 Million | -119.11 Million | -58.13 Million | -91.92 Million | -402.34 Million | -92.36 Million |
| Investments in PPE | -151.6 Million | -119.12 Million | -58.23 Million | -83.8 Million | -409.25 Million | -112.36 Million |
| Acquisitions | 24.5 Million | 5000.00 | 98.9 Thousand | 19.6 Million | 19.6 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 8940.33 | - |
| Other Investing Activities | 57.93 | 5000.00 | 98.9 Thousand | -8.12 Million | 6.89 Million | 20 Million |
| Financing Cash Flow | -75.29 Million | 249.89 Million | 45.28 Million | 34.86 Million | 15.59 Million | 7.04 Million |
| Debt repayment | -70.49 Million | -231.18 Million | -48.38 Million | -10.68 Million | -3.31 Million | -70 Million |
| Dividends payments | -4.8 Million | -5.12 Million | -3.09 Million | -4.55 Million | -6.09 Million | -2.88 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | 19.26 Million | -3.09 Million | 19.62 Million | 18.37 Million | 79.92 Million |
| Accounts receivables | - | 1.66 Million | - | -60.59 Million | -60.59 Million | 15.7 Million |
| Accounts payables | - | - | - | - | 62.04 Million | - |
| Inventory | - | 6.59 Million | - | -9.76 Million | -9.76 Million | 23.55 Million |
| Other working capital | - | 1.4 Million | - | 1.68 Million | 1.68 Million | -1.37 Million |
| Cash at beginning of period | 249.25 Million | 116.79 Million | 96.22 Million | 94.77 Million | 415.14 Million | 131.13 Million |
| Cash at end of period | 81.61 Million | 304.29 Million | 59.42 Million | 96.2 Million | 96.2 Million | 94.77 Million |
| Capital Expenditure | -151.6 Million | -119.12 Million | -58.23 Million | -83.8 Million | -409.25 Million | -112.36 Million |
| Effect of forex changes on cash | 102.67 Thousand | 729.47 Thousand | 271.08 Thousand | -237.48 Thousand | -321.13 Thousand | 138.42 Thousand |
| Net cash flow / Change in cash | -167.63 Million | 187.5 Million | -36.79 Million | 1.43 Million | -318.94 Million | -36.36 Million |
| Free Cash Flow | -92.43 Million | -60.78 Million | -82.45 Million | -25.07 Million | -341.12 Million | -63.54 Million |
4845
MGRM
300554
DXC
STYLAMIND
KKCL